Recruiting
Phase 2

Immunotherapy & Irreversible Electroporation

Sponsor:

University of Louisville

Code:

NCT03080974

Conditions

Pancreatic Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Irreversible Electroporation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by University of Louisville on 2025-02-25.